STRATIFYING EYELID MALIGNANCIES: A STUDY OF THE TUMORS PRESENTING TO A TERTIARY CARE HOSPITAL IN PAKISTAN
DOI:
https://doi.org/10.70520/kjms.v18i1.684Keywords:
Eyelid, tumor, malignancies, stratifying, ophthalmologyAbstract
Background: Eyelid malignancies are relatively uncommon, but because of their propensity for local invasion and impact on ocular function due to the complexity of reconstruction, they pose a significant challenge.
Objective: To evaluate the histological subtypes, clinical outcomes, and demographic trends of patients with malignant eyelid tumors in a tertiary care hospital in Peshawar, Pakistan.
Methods: A descriptive cross-sectional study was conducted at the Ophthalmology Department of Hayatabad Medical Complex, Peshawar, Pakistan. Eyelid tumors were classified based on histological examination of biopsy samples. Statistical analysis was performed with SPSS Version 25.0, with statistical significance set at p <0.05.
Results: A total of 125 patients had malignant eyelid tumors. The majority 52% were males; ages ranging from 30 to 60 years, while females constituted 48%. Basal cell carcinoma had the highest prevalence of all the malignancies at 72% and typically involved the lower lid in about 56%, whereas surgical resection was the standard treatment in almost all cases. Malignant melanoma and sebaceous gland carcinoma showed the highest recurrence rates at 20% each, whereas basal cell carcinoma had the lowest rate at 5.6%.
Conclusion: The most common type of malignant eyelid tumor in this study was basal cell carcinoma, consistent with local and global epidemiological patterns. The main course of treatment is still surgical excision, supplemented with adjuvant and reconstructive therapies according to necessity.
References
REFERENCES
1. Remington LA, Goodwin D. Clinical Anatomy and Physiology of the Visual System E-book: Clinical Anatomy and Physiology of the Visual System E-book. Elsevier Health Sciences; 2021 Jun 25.
2. Brown HH. Diseases of the eye and ocular adnexa. InSurgical pathology of the head and neck 2019 Jan 15 (pp. 1637-1694). CRC Press.
3. Cassel GH. The eye book: a complete guide to eye disorders and health. JHU Press; 2021 Apr 27.
4. Brodowski R, Pakla P, Dymek M, Migut M, Ambicki M, Stopyra W, Ozga D, Lewandowski B. Clinical-pathological characteristics of patients treated for cancers of the eyelid skin and periocular areas. Advances in Clinical & Experimental Medicine. 2019 Mar 1;28(3). http://doi:10.17219/acem/78023. PMID: 30277668.
5. Hui S, Dong L, Zhang K, Nie Z, Jiang X, Li H, Hou Z, Ding J, Wang Y, Li D. Noninvasive identification of Benign and malignant eyelid tumors using clinical images via deep learning system. Journal of Big Data. 2022 Jun 22;9(1):84.
6. Singh U, Kolavali RR. Overview of eyelid tumors. Surgical Ophthalmic Oncology: A Collaborative Open Access Reference. 2019:3-10.
7. Srivastava A, Sharan S. Sebaceous gland carcinoma of the ocular region in India: A brief literature review for disease management. Latin American Journal of Ophthalmology. 2021 Aug 14;4.
8. Sun MT, Huang S, Huilgol SC, Selva D. Eyelid lesions in general practice. Australian Journal of General Practice. 2019 Aug;48(8):509-14. http://doi:10.31128/AJGP-03-19-4875. PMID: 31370126.
9. Alzubaidi L, Zhang J, Humaidi AJ, Al-Dujaili A, Duan Y, Al-Shamma O, Santamaría J, Fadhel MA, Al-Amidie M, Farhan L. Review of deep learning: concepts, CNN architectures, challenges, applications, future directions. Journal of Big Data. 2021 Dec;8:1-74. http://doi:10.1186/s40537021-00444-8. Epub 2021 Mar 31. PMID: 33816053; PMCID: PMC8010506.
10. Remington LA, Goodwin D. Clinical Anatomy and Physiology of the Visual System E-book: Clinical Anatomy and Physiology of the Visual System E-book. Elsevier Health Sciences; 2021 Jun 25.
11. Carbone M, Arron ST, Beutler B, Bononi A, Cavenee W, Cleaver JE, Croce CM, D’Andrea A, Foulkes WD, Gaudino G, Groden JL. Tumor predisposition and cancer syndromes as models to study gene-environment interactions. Nature Reviews Cancer. 2020 Sep;20(9):533-49. http://doi:10.1038/s41568-020-0265-y. Epub 2020 May 29. PMID: 32472073; PMCID: PMC8104546.
12. EDITION T. MODERATE? TO? SEVERE.
13. Worley B, Owen JL, Barker CA, Behshad R, Bichakjian CK, Bolotin D, Bordeaux JS, Bradshaw S, Cartee TV, Chandra S, Cho N. Evidence-based clinical practice guidelines for microcystic adnexal carcinoma: informed by a systematic review. JAMA Dermatology. 2019 Sep 1;155(9):1059-68. http://doi:10.1001/jamadermatol.2019.1251. PMID: 31268498.
14. Pridavkova Z, Furdová A, Kapitánová KB, Vida R, Žiak P, Popov I. Periocular basal cell carcinoma of the eyelids–review. J Ophthalmol Ukraine. 2023 Jan 1;1:61-7.
15. Alfaar AS, Suckert CN, Rehak M, Girbardt C. The epidemiology of adults' eyelid malignancies in Germany between 2009 and 2015; an analysis of 42,710 patients' data. European Journal of Ophthalmology. 2023 Mar;33(2):1186-99.rac http://doi:10.1177/11206721221125018. Epub ahead of print. PMID: 36330713; PMCID: PMC9999282.
16. Oliveira D, Ribeiro A, Bacalhau C, Almada S, Diniz S. Are we Capable of Contributing to the Reduction of Eyelid Basal Cell Carcinoma? Building a Healthcare Team. Journal of Ophthalmology Research Reviews & Reports. SRC/JORRR-159. DOI: doi. org/10.47363/JORRR/2023 (4). 2023;146:2-8.
17. Furdova A, Kapitanova K, Kollarova A, Sekac J. Periocular basal cell carcinoma-clinical perspectives. Oncology Reviews. 2020 Feb 2;14(1). http://doi:10.4081/oncol.2020.420. PMID: 32395200; PMCID: PMC7204832.
18. Xu M, Chen Q, Luo Y, Chai P, He X, Huang H, Tan J, Ye J, Zhou C. Recurrence in Eyelid Sebaceous Carcinoma: A Multicentric Study of 418 Patients. Investigative Ophthalmology & Visual Science. 2024 Aug 1;65(10):4-. http://doi:10.1167/iovs.65.10.4. PMID: 39087932; PMCID: PMC11305426.
19. Ju X, Gaca P, Fan W, Rokohl AC, Guo Y, Wawer Matos PA, Emmert S, Kakkassery V, Heindl LM. Therapy failure and resistance mechanism in eyelid and ocular surface tumors. Neurosignals. 2022 Aug 25;30(S1):21-38. http://doi:10.33594/000000560. PMID: 36005157.
20. Trotier DC, Huang L, van Landingham SW, Burr AR, Ma VT. Review of recent advances in managing periocular skin malignancies. Frontiers in Oncology. 2024 Mar 4;14:1275930. http://doi:10.3389/fonc.2024.1275930. PMID: 38500654; PMCID: PMC10944901.
21. Sarfraz T, Tariq H, Iftikhar N, Raza N, Malik NA, Khan SA, Jaffar SR. Frequency and histological pattern of malignant skin lesions in Pakistani population. Pakistan Armed Forces Medical Journal. 2019 Feb 28;69(1):83-6.
Downloads
Published
How to Cite
Issue
Section
